Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer.

MedGenMed : Medscape general medicine

Volumn 7, Issue 3, 2005, Pages 20-

  Mouridsen, Henning T ^a   Robert, Nicholas J ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROSTANE DERIVATIVE; AROMATASE INHIBITOR; EXEMESTANE; LETROZOLE; NITRILE; TRIAZOLE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; POSTMENOPAUSE; REVIEW;

ANDROSTADIENES; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; FEMALE; HUMANS; NITRILES; POSTMENOPAUSE; TRIAZOLES;

EID: 33745886262     PISSN: None     EISSN: 15310132     Source Type: Journal    
DOI: None     Document Type: Review

References (52)